Population Pharmacokinetics and Pharmacodynamics (PK/PD) of Etelcalcetide for Secondary Hyperparathyroidism (sHPT) in Subjects with Chronic Kidney Disease (CKD) on Hemodialysis

Chen Ping; Narayanan Adimoolam; Wu Benjamin; Gisleskog Per Olsson; Chow Andrew T.; Gibbs John; Melhem Murad

首页> 外文期刊>Journal of pharmacokinetics and pharmacodynamics >Population Pharmacokinetics and Pharmacodynamics (PK/PD) of Etelcalcetide for Secondary Hyperparathyroidism (sHPT) in Subjects with Chronic Kidney Disease (CKD) on Hemodialysis

【24h】

Population Pharmacokinetics and Pharmacodynamics (PK/PD) of Etelcalcetide for Secondary Hyperparathyroidism (sHPT) in Subjects with Chronic Kidney Disease (CKD) on Hemodialysis

机译：依卡西肽在血液透析患者中继发性甲状旁腺功能亢进症（sHPT）的群体药代动力学和药效学（PK / PD）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of pharmacokinetics and pharmacodynamics》 |2016年第suppla期|共2页
作者
Chen Ping; Narayanan Adimoolam; Wu Benjamin; Gisleskog Per Olsson; Chow Andrew T.; Gibbs John; Melhem Murad;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Population Pharmacokinetics and Pharmacodynamics (PK/PD) of Etelcalcetide for Secondary Hyperparathyroidism (sHPT) in Subjects with Chronic Kidney Disease (CKD) on Hemodialysis [J] . Chen Ping, Narayanan Adimoolam, Wu Benjamin, Journal of pharmacokinetics and pharmacodynamics . 2016,第Suppla期

机译：依卡西肽在血液透析患者中继发性甲状旁腺功能亢进症（sHPT）的群体药代动力学和药效学（PK / PD）
2. Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis [J] . J Wilkins, P Chen, P Olsson Gisleskog, CPT: Pharmacometrics & Systems Pharmacology . 2016,第9期

机译：拟钙化依卡他肽在慢性肾脏疾病和继发性甲状旁腺功能亢进症接受血液透析的人群药代动力学和药效学
3. Clinical Pharmacokinetics and Pharmacodynamics of Etelcalcetide, a Novel Calcimimetic for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis [J] . Wu Benjamin, Melhem Murad, Subramanian Raju, The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2018,第6期

机译：Etelcalcetide的临床药代动力学和药效学，一种新型血管性慢性肾脏疾病患者继发性甲状旁腺功能亢进症
4. CHRONIOUS: An open, ubiquitous and adaptive chronic disease management platform for Chronic Obstructive Pulmonary Disease (COPD), Chronic Kidney Disease (CKD) and renal insufficiency [C] . Rosso R., Munaro G., Salvetti O., 32nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2010

机译：慢性病：针对慢性阻塞性肺疾病（COPD），慢性肾脏病（CKD）和肾功能不全的开放，无处不在的适应性慢性疾病管理平台
5. Pharmacokinetic/Pharmacodynamic Analyses of Avatrombopag in Healthy Subjects and Patients with Chronic Liver Disease [D] . NOMOTO, Maiko 2019

机译：阿法曲巴帕在健康受试者和慢性肝病患者中的药代动力学/药效学分析
6. Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis [O] . P Chen, P Olsson Gisleskog, JJ Perez‐Ruixo, 2016

机译：拟钙化依卡他肽在慢性肾脏疾病和继发性甲状旁腺功能亢进症接受血液透析的人群药代动力学和药效学
7. Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis [O] . P Chen, P Olsson Gisleskog, JJ Perez-Ruixo, 2016

机译：慢性肾疾病中钙质心甲醛的人口药代动力学和药效学和继发性血型甲状旁腺功能亢进

Population Pharmacokinetics and Pharmacodynamics (PK/PD) of Etelcalcetide for Secondary Hyperparathyroidism (sHPT) in Subjects with Chronic Kidney Disease (CKD) on Hemodialysis

著录项

相似文献

相关主题

期刊订阅